akso health group - AHG

AHG

Close Chg Chg %
1.68 0.02 1.19%

Closed Market

1.70

+0.02 (1.19%)

Volume: 955.00

Last Updated:

Oct 24, 2025, 12:30 PM EDT

Company Overview: akso health group - AHG

AHG Key Data

Open

$1.69

Day Range

1.69 - 1.70

52 Week Range

0.74 - 2.35

Market Cap

$849.87M

Shares Outstanding

551.86M

Public Float

N/A

Beta

-0.67

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.49

Yield

0.00%

Dividend

$0.38

EX-DIVIDEND DATE

Aug 1, 2018

SHORT INTEREST

N/A

AVERAGE VOLUME

26.25K

 

AHG Performance

1 Week
 
3.73%
 
1 Month
 
-2.49%
 
3 Months
 
-14.94%
 
1 Year
 
102.51%
 
5 Years
 
-18.61%
 

AHG Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About akso health group - AHG

Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. It also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S. The firm plans to open 2 vaccine research centers and 100 radiation oncology centers to be located on the east coast serving cancer patients in need of varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer related treatment services. The company was founded by Xiaobo An in March 2014 and is headquartered in Qingdao, China.

AHG At a Glance

Akso Health Group
Qiantongyuan Building
Qingdao, Shandong 266000
Phone 86-152-1005-4919 Revenue 14.80M
Industry Internet Retail Net Income -135,137,184.96
Sector Retail Trade 2025 Sales Growth 513.545%
Fiscal Year-end 03 / 2026 Employees 27
View SEC Filings

AHG Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 22.931
Price to Book Ratio 3.298
Price to Cash Flow Ratio 287.85
Enterprise Value to EBITDA -93.026
Enterprise Value to Sales 11.162
Total Debt to Enterprise Value 0.013

AHG Efficiency

Revenue/Employee 547,973.897
Income Per Employee -5,005,080.924
Receivables Turnover 1.147
Total Asset Turnover 0.075

AHG Liquidity

Current Ratio 14.199
Quick Ratio 14.185
Cash Ratio 12.758

AHG Profitability

Gross Margin -1.905
Operating Margin -26.546
Pretax Margin -1,125.136
Net Margin -913.379
Return on Assets -68.20
Return on Equity -80.084
Return on Total Capital -67.165
Return on Invested Capital -80.074

AHG Capital Structure

Total Debt to Total Equity 1.045
Total Debt to Total Capital 1.035
Total Debt to Total Assets 0.819
Long-Term Debt to Equity 0.021
Long-Term Debt to Total Capital 0.021
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Akso Health Group - AHG

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
6.33M 13.14M 2.41M 14.80M
Sales Growth
+260.43% +107.70% -81.64% +513.54%
Cost of Goods Sold (COGS) incl D&A
5.41M 11.87M 2.29M 15.08M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- - 18.43K 2.15M
-
Depreciation
- - 18.43K 1.62K
-
Amortization of Intangibles
- - - 2.15M
-
COGS Growth
+35,564.16% +119.58% -80.72% +558.55%
Gross Income
918.29K 1.26M 121.99K (281.86K)
Gross Income Growth
-47.22% +37.73% -90.36% -331.06%
Gross Profit Margin
+14.52% +9.63% +5.06% -1.91%
2022 2023 2024 2025 5-year trend
SG&A Expense
16.09M 15.48M 8.75M 3.65M
Research & Development
- - - 422.14K
-
Other SG&A
15.66M 15.48M 8.75M 3.65M
SGA Growth
-44.32% -3.74% -43.49% -58.33%
Other Operating Expense
- - - -
-
Unusual Expense
- - - 162.57M
-
EBIT after Unusual Expense
(15.17M) (14.22M) (8.63M) (166.50M)
Non Operating Income/Expense
(782.31K) 1.20M (453.21K) 34.11K
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - 805.95K
-
Interest Expense Growth
- - -62.59% -100.00%
-
Gross Interest Expense
- - - 805.95K
-
Interest Capitalized
- - - -
-
Pretax Income
(16.76M) (13.02M) (9.08M) (166.47M)
Pretax Income Growth
+46.07% +22.28% +30.27% -1,733.16%
Pretax Margin
-264.90% -99.13% -376.57% -1,125.14%
Income Tax
131.73K 17.49K 24.96K (30.84M)
Income Tax - Current - Domestic
131.73K 17.49K 24.96K 2.99K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - (30.84M)
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(16.89M) (13.04M) (9.11M) (135.63M)
Minority Interest Expense
1.33K 112.12K (57.72K) (492.35K)
Net Income
(16.89M) (13.15M) (9.05M) (135.14M)
Net Income Growth
+46.47% +22.12% +31.21% -1,393.54%
Net Margin Growth
-267.01% -100.11% -375.22% -913.38%
Extraordinaries & Discontinued Operations
- - 11.80M (3.88K)
-
Discontinued Operations
- - 11.80M (3.88K)
-
Net Income After Extraordinaries
(16.89M) (1.36M) (9.05M) (135.14M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(16.89M) (1.36M) (9.05M) (135.14M)
EPS (Basic)
-0.85 -0.0593 -0.1919 -0.474
EPS (Basic) Growth
+63.58% +93.02% -223.61% -147.00%
Basic Shares Outstanding
19.87M 22.87M 47.17M 285.10M
EPS (Diluted)
-0.85 -0.0593 -0.1919 -0.474
EPS (Diluted) Growth
+63.58% +93.02% -223.61% -147.00%
Diluted Shares Outstanding
19.87M 22.87M 47.17M 285.10M
EBITDA
(15.15M) (14.22M) (8.63M) (1.78M)
EBITDA Growth
+44.17% +6.14% +39.32% +79.42%
EBITDA Margin
-239.50% -108.23% -357.78% -12.00%

Akso Health Group in the News